Stocks and Investing Stocks and Investing
Wed, November 6, 2019
Tue, November 5, 2019

Gena Wang Initiated (VIR) at Buy and Held Target at $25 on, Nov 5th, 2019


Published on 2024-10-26 17:48:45 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Initiated "Vir Biotechnology, Inc." (VIR) at Buy and Held Target at $25 on, Nov 5th, 2019.

Gena, nor any peers, have made any analyst calls on VIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources